Clinical Trial Update: Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT [Phase 1, Phase 2]

View source ↗

Summary

A randomized trial comparing apixaban to enoxaparin for venous thromboembolism prevention after microsurgical breast reconstruction has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)
• Lovenox (enoxaparin)

Snippet

Sponsor: Stanford University | Conditions: Venous Thromboembolism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-06-22